Jubilant Life gets USFDA nod for anti-inflammatory drug savita thakur thakur30 Aug 2017 12:31 PM ISTNew Delhi: Jubilant Life Sciences Ltd said it has received the final approval for its generic version of non-steroidal anti-inflammatory drug,...
Dr Reddy's launches generic version of Suprax in US savita thakur thakur30 Aug 2017 12:31 PM ISTNew Delhi: Drug firm Dr Reddy's Laboratories said it has launched Cefixime for oral suspension, used for the treatment of bacterial infections, in the...
Sun Pharma Halol unit receives UK clearance: Report savita thakur thakur29 Aug 2017 12:44 PM ISTSun Pharmaceutical Industries' Halol unit has received clearance from the UK’s pharma regulatory body, reported a leading news daily.The company has...
Gilead to buy Kite Pharma for about 12 billion dollars savita thakur thakur29 Aug 2017 11:55 AM ISTGilead Sciences Inc has agreed to buy immunotherapy developer Kite Pharma Inc in an all-cash deal valued at 11.9 dollars billion, the companies...
DoP accepts Sun Pharmas review petition on fixing price of Volitra Enzo Tablet Ruby Khatun Khatun29 Aug 2017 9:45 AM ISTThe Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical’s review petition against price fixation of “Volitra Enzo Tablet” containing...
Titan Pharma receives FDA clearance to begin clinical study of Parkinsons disease treatment Ruby Khatun Khatun29 Aug 2017 9:32 AM ISTSOUTH SAN FRANCISCO, Calif: Titan Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New...
Class action lawsuit filed against Dr Reddy’s Laboratories in US savita thakur thakur29 Aug 2017 9:30 AM ISTNEW DELHI: Drug firm Dr Reddy's Laboratories said a class action lawsuit has been filed against it in the US by an investor alleging misleading...
Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance Ruby Khatun Khatun28 Aug 2017 4:33 PM ISTNew Delhi: Maharashtra FDA had carried out 2,540 inspections on 2,493 manufacturing units across the state since April 2016 till date and on the basis...
Piramal Enterprises aims organic growth in pharma segment Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTMumbai: Piramal Enterprises Ltd (PEL) is looking at growing organically in the pharmaceutical segment to move up the value chain and expanding in...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Propeller Health and GSK expands digital health collaboration for Asthma and COPD Ruby Khatun Khatun28 Aug 2017 9:15 AM ISTMADISON: Propeller Health, a leading digital solution for respiratory medicine, today announced the expansion of its 2015 collaboration with GSK,...
